Capturing the genAI boom for drug development [Yahoo! Finance]
![Yahoo! Finance](../../../Content/images/providers/Yahoo! Finance.png)
Bristol-Myers Squibb Company (BMY)
Last bristol-myers squibb company earnings: 2/6 07:05 am
Check Earnings Report
US:NYSE Investor Relations:
bms.com/investors.html
Company Research
Source: Yahoo! Finance
The US Food and Drug Administration (FDA) is approving more novel drugs year on year. In 2023, the agency approved 55 novel drugs – up 50% compared to 2022. With heightened drug development activity comes higher costs for companies. AI makes bringing drugs to market cheaper, faster, and more reliable, as per its proponents. Across healthcare, the AI market is expected to be worth $908.7bn by 2030 according to analysis by GlobalData. Generative AI (genAI) especially, presents a streamlined efficiency across the pharma value chain. “GenAI is revolutionising healthcare, fundamentally altering the industry's approach to efficiency and productivity,” says Saurabh Daga, associate project manager of Disruptive Tech at GlobalData. One of its most popular applications, and what many high-value pharma deals have recently centred around, is at the pre-market stages in a medicine's lifecycle. But whilst the genAI buzz engulfs the pharma landscape, there remain questions over the transpar
Show less
Read more
Impact Snapshot
Event Time:
BMY
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
BMY alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
BMY alerts
High impacting Bristol-Myers Squibb Company news events
Weekly update
A roundup of the hottest topics
BMY
News
- ???????Alumis cuts IPO size, but nets $250M for immune drug work [Yahoo! Finance]Yahoo! Finance
- Is Bristol Myers Squibb Stock a Buy? [Yahoo! Finance]Yahoo! Finance
- Bristol-Myers Squibb (NYSE: BMY) was downgraded by analysts at StockNews.com from a "strong-buy" rating to a "buy" rating.MarketBeat
- Will Bristol Myers Squibb Stock Rebound To Its 2022 Highs Of $80? [Forbes]Forbes
- Bristol Myers Squibb (BMY) Stock Declines While Market Improves: Some Information for Investors [Yahoo! Finance]Yahoo! Finance
BMY
Earnings
- 4/25/24 - Miss
BMY
Sec Filings
- 6/25/24 - Form 11-K
- 6/25/24 - Form 11-K
- 6/25/24 - Form 11-K
- BMY's page on the SEC website